Format

Send to

Choose Destination
Mayo Clin Proc. 2014 Jul;89(7):1009-20. doi: 10.1016/j.mayocp.2014.05.009.

Vascularized composite allotransplant in the realm of regenerative plastic surgery.

Author information

1
Division of Plastic Surgery & William J. von Liebig Transplant Center, Multidisciplinary Transplant Program, Mayo Clinic, Rochester, MN.
2
Division of Plastic Surgery & William J. von Liebig Transplant Center, Multidisciplinary Transplant Program, Mayo Clinic, Rochester, MN. Electronic address: Moran.steven@mayo.edu.

Erratum in

  • Mayo Clin Proc. 2014 Aug;89(8):1169.

Abstract

Vascularized composite allotransplant (VCA) has led to new treatment options for patients with severe upper extremity and facial injuries. Although VCA can restore form and function, it exposes the patient to the risks associated with lifelong immunosuppression. Hopefully, ongoing advances in regenerative medicine will someday obviate the need for VCA, but until that time, VCA remains an immediate means of reconstructing otherwise unreconstructable defects. We review the outcomes of hand and face transplants, as well as the recent developments in immunosuppression as it relates to the field of VCA.

PMID:
24996237
DOI:
10.1016/j.mayocp.2014.05.009
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center